NCT03510403View on ClinicalTrials.gov

Efficacy, Safety and Acceptability of Nastent™ in Snoring and Obstructive Sleep Apnea

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 12, 2018

Primary Completion Date

July 25, 2019

Study Completion Date

July 25, 2019

Conditions
SnoringObstructive Sleep Apnea
Interventions
DEVICE

nastent™

Snorer and OSA patients (mild or moderate OSA) use the nasal airway stent for sleeping, each night for 1 month.

Trial Locations (6)

33000

Cabinet ORL de Bordeaux, Bordeaux

34070

Beau-Soleil Private Hospital, Montpellier

75017

Centre Médical Veille Sommeil, Paris

92151

Foch Hospital, Suresnes

94010

Centre Hospitalier Intercommunal de Créteil, Créteil

Henri-Mondor Hospital, Créteil

All Listed Sponsors
collaborator

Slb Pharma

OTHER

collaborator

nastent.inc

UNKNOWN

lead

Seven Dreamers Europe SAS

INDUSTRY

NCT03510403 - Efficacy, Safety and Acceptability of Nastent™ in Snoring and Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter